These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22228201)

  • 1. Drug resistance in glioblastoma: a mini review.
    Haar CP; Hebbar P; Wallace GC; Das A; Vandergrift WA; Smith JA; Giglio P; Patel SJ; Ray SK; Banik NL
    Neurochem Res; 2012 Jun; 37(6):1192-200. PubMed ID: 22228201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
    Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
    J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.
    Johannessen TC; Bjerkvig R
    Expert Rev Anticancer Ther; 2012 May; 12(5):635-42. PubMed ID: 22594898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro.
    Peigñan L; Garrido W; Segura R; Melo R; Rojas D; Cárcamo JG; San Martín R; Quezada C
    Neurochem Res; 2011 Aug; 36(8):1397-406. PubMed ID: 21544552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cells and Chemoresistance in Glioblastoma Multiform: A Review Article.
    Safari M; Khoshnevisan A
    J Stem Cells; 2015; 10(4):271-85. PubMed ID: 27144829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Analysis of DNA Repair- and Drug-Efflux-Associated Molecules in Tumor and Peritumor Areas of Glioblastoma.
    Angelucci C; D'Alessio A; Sorrentino S; Biamonte F; Moscato U; Mangiola A; Sica G; Iacopino F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T; Mingyi M; Qiu X; Qiu Y
    Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair mechanisms help glioblastoma resist treatment.
    Atkins RJ; Ng W; Stylli SS; Hovens CM; Kaye AH
    J Clin Neurosci; 2015 Jan; 22(1):14-20. PubMed ID: 25444993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
    Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
    BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment strategies to eradicate cancer stem cells and niches in glioblastoma.
    Hide T; Makino K; Nakamura H; Yano S; Anai S; Takezaki T; Kuroda J; Shinojima N; Ueda Y; Kuratsu J
    Neurol Med Chir (Tokyo); 2013; 53(11):764-72. PubMed ID: 24140771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
    Okada M; Sato A; Shibuya K; Watanabe E; Seino S; Suzuki S; Seino M; Narita Y; Shibui S; Kayama T; Kitanaka C
    Int J Oncol; 2014 Feb; 44(2):591-9. PubMed ID: 24316756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair.
    Kim GW; Lee DH; Yeon SK; Jeon YH; Yoo J; Lee SW; Kwon SH
    Anticancer Res; 2019 Dec; 39(12):6731-6741. PubMed ID: 31810938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme?
    Gallo C; Buonerba C; Di Lorenzo G; Romeo V; De Placido S; Marinelli A
    J Neurooncol; 2010 Nov; 100(2):311-9. PubMed ID: 20556481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1.
    Chou CW; Wang CC; Wu CP; Lin YJ; Lee YC; Cheng YW; Hsieh CH
    Neuro Oncol; 2012 Oct; 14(10):1227-38. PubMed ID: 22946104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
    Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
    Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.
    Kanai R; Rabkin SD; Yip S; Sgubin D; Zaupa CM; Hirose Y; Louis DN; Wakimoto H; Martuza RL
    J Natl Cancer Inst; 2012 Jan; 104(1):42-55. PubMed ID: 22173583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma.
    Koch D; Hundsberger T; Boor S; Kaina B
    J Neurooncol; 2007 Mar; 82(1):85-9. PubMed ID: 17031555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells.
    Das A; Henderson FC; Alshareef M; Porto GBF; Kanginakudru I; Infinger LK; Vandergrift WA; Lindhorst SM; Varma AK; Patel SJ; Cachia D
    Clin Transl Oncol; 2021 Mar; 23(3):612-619. PubMed ID: 32710211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
    William D; Walther M; Schneider B; Linnebacher M; Classen CF
    PLoS One; 2018; 13(1):e0191511. PubMed ID: 29352318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.